Sanofi-Aventis SpA in Consumer Health (Italy)
Sanofi-Aventis plans to invest heavily in new product development in the forecast period, aiming to launch two new drugs a year over 2016-2018. The company will however focus new product development on Rx medicines, with a focus on rare diseases, diabetes, cardiovascular diseases and immunology. Within consumer health, the company is meanwhile likely to focus on growing sales in vitamins and dietary supplements, where it is likely to slowly expand its range in line with changing consumer needs.
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook